Formulation and Evaluation of Floating Sustain Release Pellets of Anti Gout Drug
Upasana J. Patel, Hiteshkumar A. Patel
Journal of Pharmaceutical Research International · pp. 2858–2866 · Published 27 Dec 2021
10.9734/jpri/2021/v33i60B34952Abstract
Objective: The objective of this investigation was to formulate and evaluate effervescent pellets of febuxostat to achieve sustain release effect. Place and Duration of Study: APMC College of Pharmaceutical education and research, Department of Pharmaceutics, Himatnagar-383001, between June 2019 and July 2021. Materials and Methods: The gastro retentive effervescent pellets of febuxostat were formulated using Sodium CMC and HPMC K4M and HPMCK15M as a sustain release polymer. Pellets were prepared by extrusion- spheronization technique using microcrystalline cellulose as spheronizing agent and sodium bicarbonate and citric acid as a gas forming agent for effervescent pellets. The pellets were characterized with respect to their floating lag time, total buoyancy time and % cumulative drug release. Results and Discussion: DSC study showed that there was no change in the melting endotherm of the drug and drug-polymers mixture which means drug and polymers were compatible with each other. The optimized formulation B14 exhibits a floating lag time 4.00±0.004 sec. and cumulative % drug release at 12th hour 99.58±0.02. Scanning electron microscopy photomicrograph revealed that the surface was rough and pellets were spherical shaped in nature. Conclusion: Febuxostat sustain release pellets was successfully formulated and evaluated as effervescent pellets with gas former agents and sustain release polymer HPMC K15.
Cited by 0
No indexed citations yet.
Related research
- Ten Years Milestones in Xanthine Oxidase Inhibitors Discovery: Febuxostat-Based Inhibitors Trends, Bifunctional Derivatives, and Automatized Screening Assays — shares topic coverage
- Timed Administration of Febuxostat Improved Testicular Function Following Testicular Ischemia-reperfusion Injury Via Inhibition of MDA/NO Pathway, Down-regulation of Toll-like Receptor 4 Expression and Restoration of Reproductive Hormones — shares topic coverage
- Assessment of the Impact of APEX1 (rs2307486) and URAT1 (rs11231825) Gene Polymorphisms on the Response of Hypouricemic Therapy in Women with Gout — shares topic coverage
- Management of Gout in Chronic Kidney Disease — shares topic coverage
- A Review on Better Analytical Technique for Determining Febuxostat in the Blood Plasma for Bioavailability and Bioequivalence Studies — shares topic coverage
Article metrics
Real usage data collected on this platform.
3
Page views
0
PDF downloads
7
Outbound clicks
0
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.